Jorge da Silva
Oprichter bij MOONLAKE IMMUNOTHERAPEUTICS
Vermogen: 134 M $ op 30-04-2024
Profiel
Jorge Santos da Silva is the founder of Moonlake Immunotherapeutics AG, founded in 2021, where he holds the title of Chief Executive Officer.
He is also the founder of MoonLake Immunotherapeutics, founded in 2022, where he currently holds the title of Chief Executive Officer & Director.
Dr. da Silva's current job is as a Professor at the University of Minho, where he is currently employed.
He previously worked as a Senior Partner at McKinsey & Co., Inc. Dr. da Silva's education history includes an undergraduate degree from the University of Glasgow and a doctorate degree from the University of Turin.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-03-2024 | 2 982 814 ( 4.98% ) | 126 M $ | 30-04-2024 | |
| 15-03-2024 | 196 316 ( 2.19% ) | 8 M $ | 30-04-2024 |
Actieve functies van Jorge da Silva
| Bedrijven | Functie | Begin |
|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Oprichter | 05-04-2022 |
| University of Minho | Corporate Officer/Principal | - |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Algemeen Directeur | 01-07-2021 |
Eerdere bekende functies van Jorge da Silva
| Bedrijven | Functie | Einde |
|---|---|---|
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-06-2021 |
Opleiding van Jorge da Silva
| University of Turin | Doctorate Degree |
| University of Glasgow | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Health Technology |